LUNDBECK
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing, and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. According to the World Health Organization, WHO, more than 700 mil... lion cases of psychiatric and neurological disorders are reported every year. These are serious and life-threatening diseases that affect the quality of life of the patients as well as of their relatives. As these diseases also involve major socio-economic costs, it is imperative for the general society that new and innovative pharmaceuticals are developed. Over the past 50 years, new pharmaceuticals have revolutionized the treatment options, but there remains a large unmet need for new and innovative therapeutics. Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with psychiatric and neurological disorders. We are specialists in our area and have research facilities in Denmark and China, and more than 1,000 employees work in our R&D units. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions. Lundbeck employs approximately 5,300 people worldwide, 1,700 of whom are based in Denmark. We have employees in 55 countries, and our products are registered in more than 100 countries. We have production facilities in China, Denmark, France and Italy and research centers in Denmark and China.
LUNDBECK
Industry:
Health Care Health Diagnostics Medical
Founded:
2000-01-01
Address:
Valby, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.lundbeck.com
Total Employee:
5001+
Status:
Active
Contact:
866-337-6996
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Mobile Non Scaleable Content Nginx Euro IPv6
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Syrona Health
Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2019-09-16 | Alder Biopharmaceuticals | Alder Biopharmaceuticals acquired by Lundbeck | 1.95 B USD |
2019-05-06 | Abide Therapeutics | Abide Therapeutics acquired by Lundbeck | 250 M USD |
2018-03-16 | Prexton Therapeutics | Prexton Therapeutics acquired by Lundbeck | 905 M EUR |
2014-05-08 | Chelsea Therapeutics International | Chelsea Therapeutics International acquired by Lundbeck | 658 M USD |
2009-10-07 | Laboratoire Elaiapharm | Laboratoire Elaiapharm acquired by Lundbeck | N/A |
2009-03-19 | Ovation Pharmaceuticals | Ovation Pharmaceuticals acquired by Lundbeck | N/A |
2002-11-21 | Synaptic Pharmaceuticals | Synaptic Pharmaceuticals acquired by Lundbeck | 121 M USD |
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Lundbeck
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2015-08-26 | BenevolentAI | Lundbeck investment in Venture Round - BenevolentAI | 87 M USD |
2014-05-06 | Naurex | Lundbeck investment in Series C - Naurex | 25 M USD |
2011-09-29 | Proximagen | Lundbeck investment in Venture Round - Proximagen | 16 M USD |
Official Site Inspections
http://www.lundbeck.com Semrush global rank: 591.71 K Semrush visits lastest month: 77.42 K
- Host name: server-99-84-208-68.iad79.r.cloudfront.net
- IP address: 99.84.208.68
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108